Structural Insight into the interaction of Flavonoids with Human Telomeric Sequence

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Tawani, Arpita ^a   Kumar, Amit ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY INDORE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA; FLAVONOID; GUANINE QUADRUPLEX;

ANIMAL; BOVINE; CHEMISTRY; HUMAN; TELOMERE;

ANIMALS; ANTINEOPLASTIC AGENTS; CATTLE; DNA; FLAVONOIDS; G-QUADRUPLEXES; HUMANS; TELOMERE;

EID: 84948951088     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17574     Document Type: Article

References (54)

1. Hayflick, L. & Moorhead, P. S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585-621 (1961).
2. Harley, C. B., Futcher, A. B. & Greider, C. W. Telomeres shorten during ageing of human fibroblasts. Nature 345, 458-460 (1990).
3. Stewart, S. A. & Weinberg, R. A. Telomeres: cancer to human aging. Annu. Rev. Cell Dev. Biol. 22, 531-557 (2006).
4. Kim, N. W. et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015 (1994).
5. Greider, C. W. Telomere length regulation. Annu. Rev. Biochem. 65, 337-365 (1996).
6. Nakamura, T. M. et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955-959 (1997).
7. Feng, J. et al. The RNA component of human telomerase. Science 269, 1236-1241 (1995).
8. Zahler, A. M., Williamson, J. R., Cech, T. R. & Prescott, D. M. Inhibition of telomerase by G-quartet DNA structures. Nature 350, 718-720 (1991).
9. Fletcher, T. M., Sun, D., Salazar, M. & Hurley, L. H. Effect of DNA secondary structure on human telomerase activity. Biochemistry 37, 5536-5541 (1998).
10. De Cian, A. et al. Targeting telomeres and telomerase. Biochimie 90, 131-155 (2008).
11. Ou, T. M. et al. G-quadruplexes: targets in anticancer drug design. Chem Med Chem 3, 690-713 (2008).
12. Ferreira, R. et al. Structure and stability of human telomeric G-quadruplex with preclinical 9-amino acridines. PloS one 8, e57701 (2013).
13. Mergny, J. L. et al. The development of telomerase inhibitors: the G-quartet approach. Anti-cancer Drug Des. 14, 327-339 (1999).
14. Perry, P. J. & Jenkins, T. C. Recent advances in the development of telomerase inhibitors for the treatment of cancer. Expert Opin. Investig. Drugs 8, 1981-2008 (1999).
15. Raymond, E. et al. DNA G-quadruplexes, telomere-specific proteins and telomere-associated enzymes as potential targets for new anticancer drugs. Invest. New Drugs 18, 123-137 (2000).
16. Neidle, S. & Parkinson, G. Telomere maintenance as a target for anticancer drug discovery. Nat. Rev. Drug Discov. 1, 383-393 (2002).
17. Franceschin, M. et al. Natural and synthetic G-quadruplex interactive berberine derivatives. Bioorg. Med. Chem. Lett. 16, 1707-1711 (2006).
18. Bessi, I. et al. Spectroscopic, molecular modeling, and NMR-spectroscopic investigation of the binding mode of the natural alkaloids berberine and sanguinarine to human telomeric G-quadruplex DNA. ACS Chem. Biol. 7, 1109-1119 (2012).
19. Maiti, M. & Kumar, G. S. Polymorphic nucleic Acid binding of bioactive isoquinoline alkaloids and their role in cancer. J. Nucleic Acids 2010 (2010).
20. Bhadra, K. & Kumar, G. S. Interaction of berberine, palmatine, coralyne, and sanguinarine to quadruplex DNA: a comparative spectroscopic and calorimetric study. Biochim. Biophys. Acta 1810, 485-496 (2011).
21. Liu, Y., Zheng, B., Xu, X. & Yuan, G. Probing the binding affinity of small-molecule natural products to the G-quadruplex in C-myc oncogene by electrospray ionization mass spectrometry. Rapid. Commun. Mass Spectrom. 24, 3072-3075 (2010).
22. Fedoroff, O. Y. et al. NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA. Biochemistry 37, 12367-12374 (1998).
23. Carini, J. P., Klamt, F. & Bassani, V. L. Flavonoids from Achyrocline satureioides: promising biomolecules for anticancer therapy. RSC Advances 4, 3131 (2014).
24. Bjeldanes, L. F. & Chang, G. W. Mutagenic activity of quercetin and related compounds. Science 197, 577-578 (1977).
25. Rueff, J. et al. Genetic toxicology of flavonoids: the role of metabolic conditions in the induction of reverse mutation, SOS functions and sister-chromatid exchanges. Mutagenesis 1, 179-183 (1986).
26. Kessler, M., Ubeaud, G. & Jung, L. Anti- and pro-oxidant activity of rutin and quercetin derivatives. J. Pharm. Pharmacol. 55, 131-142 (2003).
27. Chowdhury, A. R. et al. Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I. Biochem. J. 366, 653-661 (2002).
28. Bhatia, N. & Agarwal, R. Detrimental effect of cancer preventive phytochemicals silymarin, genistein and epigallocatechin 3-gallate on epigenetic events in human prostate carcinoma DU145 cells. Prostate 46, 98-107 (2001).
29. Sengupta, B. & Sengupta, P. K. The interaction of quercetin with human serum albumin: a fluorescence spectroscopic study. Biochem. Biophys. Res. Commun. 299, 400-403 (2002).
30. Snyder, R. D. & Gillies, P. J. Reduction of genistein clastogenicity in Chinese hamster V79 cells by daidzein and other flavonoids. Food Chem. Toxicol. 41, 1291-1298 (2003).
31. Ren, W., Qiao, Z., Wang, H., Zhu, L. & Zhang, L. Flavonoids: promising anticancer agents. Med. Res. Rev. 23, 519-534 (2003).
32. Kuntz, S., Wenzel, U. & Daniel, H. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur. J. Nutr. 38, 133-142 (1999).
33. Zhang, Q., Zhao, X. H. & Wang, Z. J. Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. Food Chem. Toxicol. 46, 2042-2053 (2008).
34. Saretzki, G. Telomerase inhibition as cancer therapy. Cancer Lett. 194, 209-219 (2003).
35. Solimani, R. et al. Flavonoid-DNA Interaction Studied with Flow Linear Dichroism Technique. J. Agric. Food Chem. 43, 876-882 (1995).
36. Solimani, R. Quercetin and DNA in solution: analysis of the dynamics of their interaction with a linear dichroism study. Int. J. Biol. Macromol. 18, 287-295 (1996).
37. Kanakis, C. D., Tarantilis, P. A., Polissiou, M. G., Diamantoglou, S. & Tajmir-Riahi, H. A. An overview of DNA and RNA bindings to antioxidant flavonoids. Cell Biochem. Biophys. 49, 29-36 (2007).
38. Ragazzon, P. A., Bradshaw, T., Matthews, C., Iley, J. & Missailidis, S. The characterisation of flavone-DNA isoform interactions as a basis for anticancer drug development. Anticancer Res. 29, 2273-2283 (2009).
39. Sun, H. et al. Spectroscopic studies of the interaction between quercetin and G-quadruplex DNA. Bioorg. Med. Chem. Lett. 16, 3586-3589 (2006).
40. Burda, S. & Oleszek, W. Antioxidant and antiradical activities of flavonoids. J. Agric. Food Chem. 49, 2774-2779 (2001).
41. Tysoe, S. A., Morgan, R. J., Baker, A. D. & Strekas, T. C. Spectroscopic investigation of differential binding modes of. DELTA.- and. LAMBDA.-Ru(bpy)2(ppz)2+ with calf thymus DNA. J. Phys. Chem. 97, 1707-1711 (1993).
42. Kang, J. et al. Electrochemical investigation on interaction between DNA with quercetin and Eu-Qu3 complex. J. Inorg. Biochem. 98, 79-86 (2004).
43. Ambrus, A. et al. Human telomeric sequence forms a hybrid-type intramolecular G-quadruplex structure with mixed parallel/antiparallel strands in potassium solution. Nucleic Acids Res. 34, 2723-2735 (2006).
44. Gavathiotis, E. & Searle, M. S. Structure of the parallel-stranded DNA quadruplex d(TTAGGGT)4 containing the human telomeric repeat: evidence for A-tetrad formation from NMR and molecular dynamics simulations. Org. Biomol. Chem. 1, 1650-1656 (2003).
45. Simonsson, T., Pecinka, P. & Kubista, M. DNA tetraplex formation in the control region of c-myc. Nucleic Acids Res. 26, 1167-1172 (1998).
46. Burge, S., Parkinson, G. N., Hazel, P., Todd, A. K. & Neidle, S. Quadruplex DNA: sequence, topology and structure. Nucleic Acids Res. 34, 5402-5415 (2006).
47. Woodford, K. J., Howell, R. M. & Usdin, K. A novel K(+)-dependent DNA synthesis arrest site in a commonly occurring sequence motif in eukaryotes. J. Biol. Chem. 269, 27029-27035 (1994).
48. Fedoroff, O. Y. et al. NMR-Based Model of a Telomerase-Inhibiting Compound Bound to G-Quadruplex DNA†. Biochemistry 37, 12367-12374 (1998).
49. Wei, C., Wang, J. & Zhang, M. Spectroscopic study on the binding of porphyrins to (G(4)T(4)G(4))4 parallel G-quadruplex. Biophys. Chem. 148, 51-55 (2010).
50. Jeener, J., Meier, B. H., Bachmann, P. & Ernst, R. R. Investigation of exchange processes by two-dimensional NMR spectroscopy. J. Chem. Phys. 71, 4546-4553 (1979).
51. Brooks, B. R. et al. CHARMM: the biomolecular simulation program. J. Comput. Chem. 30, 1545-1614 (2009).
52. Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926-935 (1983).
53. Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: An N·log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089-10092 (1993).
54. Ryckaert, J.-P., Ciccotti, G. & Berendsen, H. J. C. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 23, 327-341 (1977).